St. Francis predicts X-Stop launch in mid-2005
This article was originally published in The Gray Sheet
FDA-requested information to support approval for firm's X-Stop non-fusion lumbar device is "reasonable" and "readily available," President & CEO Kevin Sidow states. St. Francis will submit the requested data quickly, he says. In September, FDA's Orthopaedic & Rehabilitation Devices Panel voted 5-3 against approval of the device, which is meant to treat lumbar spinal stenosis, due to a lack of radiographic data proving reduction of stenosis-induced pressure on spinal nerve roots (1"The Gray Sheet" Sept. 6, 2004, p. 7). Sidow believes X-Stop is on track for a mid-2005 release in the U.S. Currently, the device is approved in Europe and Japan...
You may also be interested in...
St. Francis Medical should collect more detailed radiographic data of its X-Stop non-fusion lumbar device to prove reduction of stenosis-induced pressure on spinal nerve roots, FDA panelists urged Aug. 31
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.